Manish Bhandari
About
In The Last Decade
Manish Bhandari
28 papers receiving 269 citations
Peers
Comparison fields: 5 of 76
- Molecular Biology 103
- Oncology 95
- Pulmonary and Respiratory Medicine 83
- Hematology 80
- Cancer Research 26
Countries citing papers authored by Manish Bhandari
This map shows the geographic impact of Manish Bhandari's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Manish Bhandari with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Manish Bhandari more than expected).
Fields of papers citing papers by Manish Bhandari
This network shows the impact of papers produced by Manish Bhandari. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Manish Bhandari. The network helps show where Manish Bhandari may publish in the future.
Co-authorship network of co-authors of Manish Bhandari
This figure shows the co-authorship network connecting the top 25 collaborators of Manish Bhandari. A scholar is included among the top collaborators of Manish Bhandari based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Manish Bhandari. Manish Bhandari is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 2 | |
| 2 | 0 | |
| 3 | 2 | |
| 4 | 11 | |
| 5 | 1 | |
| 6 | 1 | |
| 7 | Applications of Functionally Graded Materials (FGMs) | 15 |
| 8 | 3 | |
| 9 | 1 | |
| 10 | 1 | |
| 11 | 1 | |
| 12 | 2 | |
| 13 | 60 | |
| 14 | 6 | |
| 15 | 33 | |
| 16 | 21 | |
| 17 | 50 | |
| 18 | 1 | |
| 19 | 5 | |
| 20 | Surrogate endpoint biomarker assays in phase II chemoprevention clinical trials. | 4 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.